In breast cancer cell lines, multiple studies have shown that LRH-1 has tumour-promoting roles in estrogen production, estrogen receptor (ER) signalling, cell cycle control, and cellular migration and invasion [1, 7, 8, 10–15]. Here, NR5A2 is linked to breast carcinoma.